| 1 | ALKAS, CCNQ, CDK10, ELS2, PKN2
|
| CDK10 Mutations in Humans and Mice Cause Severe Growth Retardation, Spine Malformations, and Developmental Delays.
|
| Windpassinger C, Piard J, Bonnard C, Alfadhel M, Lim S, Bisteau X, Blouin S, Ali NB, Ng AYJ, Lu H, Tohari S, Talib SZA, van Hul N, Caldez MJ, Van Maldergem L, Yigit G, Kayserili H, Youssef SA, Coppola V, de Bruin A, Tessarollo L, Choi H, Rupp V, Roetzer K, Roschger P, Klaushofer K, Altmüller J, Roy S, Venkatesh B, Ganger R, Grill F, Ben Chehida F, Wollnik B, Altunoglu U, Al Kaissi A, Reversade B, Kaldis P.
|
| Am J Hum Genet 101(3):391-403. doi: 10.1016/j.ajhg.2017.08.003. 2017
|
| 2 | CCNQ, CDK10, STARS
|
| STAR syndrome-associated CDK10/Cyclin M regulates actin network architecture and ciliogenesis.
|
| Guen VJ, Gamble C, Perez DE, Bourassa S, Zappel H, Gärtner J, Lees JA, Colas P.
|
| Cell Cycle 15(5):678-88. doi: 10.1080/15384101.2016.1147632. 2016
|
| 3 | CDK10
|
| Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report.
|
| You Y, Li H, Qin X, Zhang Y, Song W, Ran Y, Gao F.
|
| Cell Oncol (Dordr) 38(6):485-91. doi: 10.1007/s13402-015-0246-4. Epub 2015 Sep 21. 2015
|
| 4 | CCNQ, CDK10
|
| CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.
|
| Guen VJ, Gamble C, Flajolet M, Unger S, Thollet A, Ferandin Y, Superti-Furga A, Cohen PA, Meijer L, Colas P.
|
| Proc Natl Acad Sci U S A 110(48):19525-30. doi: 10.1073/pnas.1306814110. Epub 2013 Nov 11. 2013
|
| 5 | CDK10, RAF1
|
| Knockdown of cyclin-dependent kinase 10 (cdk10) gene impairs neural progenitor survival via modulation of raf1a gene expression.
|
| Yeh CW, Kao SH, Cheng YC, Hsu LS.
|
| J Biol Chem 288(39):27927-39. doi: 10.1074/jbc.M112.420265. Epub 2013 Jul 31. 2013
|
| 6 | CDK10
|
| CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells.
|
| Yu JH, Zhong XY, Zhang WG, Wang ZD, Dong Q, Tai S, Li H, Cui YF.
|
| Oncol Rep 27(4):1266-76. doi: 10.3892/or.2011.1617. Epub 2011 Dec 30.
2012
|
| 7 | CDK10
|
| CDK10 is not a target for aberrant DNA methylation in breast cancer.
|
| Heller G, Ziegler B, Brandstetter A, Novak S, Rudas M, Hennig G, Gehrmann M, Acht T, Zöchbauer-Müller S, Filipits M.
|
| Anticancer Res 29(10):3939-44.
2009
|
| 8 | CDK10
|
| Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle.
|
| Bagella L, Giacinti C, Simone C, Giordano A.
|
| J Cell Biochem 99(3):978-85.
2006
|
| 9 | CDK10
|
| Human CDK10 gene isoforms.
|
| Sergere JC, Thuret JY, Le Roux G, Carosella ED, Leteurtre F.
|
| Biochem Biophys Res Commun 276(1):271-7. 2000
|
| 10 | CDK10
|
| The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer.
|
| Crawford J, et al.
|
| Genomics 56(1):90-7. 1999
|
| 11 | RPL13, CDK10, SPG7, DPEP1, FANCA, MC1R, CHMP1A
|
| Construction of a high-resolution physical and transcription map of chromosome 16q24.3 : a region of frequent loss of heterozygosity in sporadic breast cancer.
|
| Whitmore SA, et al.
|
| Genomics 50 : 1-8. 1998
|
| 12 | CDK10
|
| The cdc2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle.
|
| Li S, et al.
|
| Cancer Res 55 : 3992-3995. 1995
|
| 13 | CDK10, CDK9, CDK3, CDK6, CDKN1B
|
| Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer.
|
| Bullrich F, et al.
|
| Cancer Res 55 : 1199-1205. 1995
|
| 14 | CDK10
|
| Molecular cloning of PISSLRE, a novel putative member of the cdk family of protein serine/threonine kinases.
|
| Brambilla R, et al.
|
| Oncogene 9 : 3037-3041. 1994
|
| 15 | CDK10
|
| PISSLRE, a human novel CDC2-related protein kinase.
|
| Grana X, et al.
|
| Oncogene 9 : 2097-2103. 1994
|